Brief: NRx Pharmaceuticals Says Co To Present Full Compliance Plan To Nasdaq on January 4, 2024
02/01/2024 12:22
Jan 2 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS (NASDAQ: NRXP) DEMONSTRATES COMPLIANCE
WITH
NASDAQ MVLS STANDARD
* NRX PHARMACEUTICALS INC: TO PRESENT FULL COMPLIANCE PLAN,
BASED
ON ACHIEVING CLINICAL MILESTONES, TO NASDAQ ON JANUARY 4, 2024
Source text for Eikon: ID:nPnbDmx1da
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview